AGM/EGMJun 4, 2026, 07:31 AM
Advanced Biomed Inc. Schedules Annual Meeting for June 30, 2026
AI Summary
Advanced Biomed Inc. has filed its Definitive Proxy Statement for the Annual Meeting of Stockholders scheduled for June 30, 2026. Key agenda items include the election of five directors, an advisory vote on executive compensation, determining the frequency of future advisory votes on executive compensation, and ratifying WWC, P.C. as the independent auditor. The company also announced a recent leadership transition with Xiaomin Chen becoming Chairman and CEO and the acquisition of Acellent Technologies (Hong Kong) Co. Limited. The Board of Directors recommends favorable votes on all proposals.
Key Highlights
- Advanced Biomed Inc. will hold its Annual Meeting of Stockholders on June 30, 2026, at 10:00 a.m. Eastern Time in Tainan City, Taiwan.
- Stockholders will vote on electing five directors, advisory approval of executive compensation, frequency of advisory votes on executive compensation, and ratification of the independent auditor.
- The Board of Directors recommends voting 'FOR' director nominees, 'FOR' executive compensation approval, 'ONE YEAR' for compensation vote frequency, and 'FOR' auditor ratification.
- The company completed a leadership transition with Xiaomin Chen appointed Chairman and CEO in April 2026.
- Aellent Technologies (Hong Kong) Co. Limited was acquired in April 2026, focusing on AI and trustworthy AI verification systems.
- WWC, P.C. is proposed as the independent registered public accounting firm for the fiscal year ending June 30, 2026.
- The Record Date for voting eligibility is May 29, 2026, with 1,652,133 shares of common stock outstanding.
Price Impact
More from ADVB